http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108380241-B
Outgoing Links
Predicate | Object |
---|---|
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C02F2101-38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C02F2305-10 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C02F1-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01J35-004 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01J29-48 |
classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C02F101-38 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C02F1-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B01J29-48 |
filingDate | 2018-03-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2020-12-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2020-12-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-108380241-B |
titleOfInvention | Z-type photocatalyst BiPO4Preparation and application of/H-ZSM-5/BiOCl |
abstract | The invention relates to a Z-type photocatalyst BiPO 4 A preparation method of/H-ZSM-5/BiOCl belongs to the field of modification preparation of photocatalytic materials. The Z-type photocatalyst BiPO of the invention 4 The preparation method of the/H-ZSM-5/BiOCl comprises the steps of firstly preparing the composite photocatalyst H-ZSM-5/BiOCl. Then dispersing the prepared H-ZSM-5/BiOCl composite photocatalyst in 50mL of phosphoric acid solution with certain concentration, continuously stirring for 90min, then performing ultrasonic treatment for 10min, naturally standing, removing supernatant, and drying in a 65 ℃ oven for 20H to obtain the Z-type photocatalyst BiPO 4 H-ZSM-5/BiOCl. Compared with the photocatalyst BiOCl, the degradation rate of the H-ZSM-5/BiOCl composite photocatalyst prepared by the invention to carbamazepine at room temperature for 30min is improved by nearly 10%, and the Z-type photocatalyst BiPO 4 Compared with the photocatalyst BiOCl, the degradation rate of the/H-ZSM-5/BiOCl to carbamazepine is improved by more than twenty percent, and the photocatalyst BiOCl has good application prospect. |
priorityDate | 2018-03-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 30.